Projects per year
The Hybridoma Facility will be housed in the Biohazard Facility where it will make and human monoclonal antibodies that react with HIV and its components. It will also carry out serological analysis on potentially biohazardous material.
|Effective start/end date||10/1/87 → 9/30/93|
- National Institute of Allergy and Infectious Diseases
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.